Q&A

Oral topiramate effective for alcoholism

Author and Disclosure Information

  • BACKGROUND: Alcohol dependence is a fairly common problem seen in family practice. To date, there have been few, if any, effective medications that help patients control or reduce their drinking behavior.
  • POPULATION STUDIED: These researchers enrolled 150 patients with alcohol dependence, as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), into the study. They randomly assigned subjects to treatment or placebo groups.
  • STUDY DESIGN AND VALIDITY: Patients were randomly assigned to receive escalating doses of either topiramate (maximum of 300 mg/d) or placebo for a period of 12 weeks. Subjects, clinicians, and those assessing treatment outcomes were blind to group assignment; however, it is unclear whether allocation to the groups was concealed.
  • OUTCOMES MEASURED: The investigators measured 6 primary outcomes on a weekly basis throughout the 12 weeks of the study. They assessed the number of drinks per day, drinks per drinking day, heavy drinking days (defined as 5 or more drinks for men or 4 or more drinks for women), and number of days abstinent.
  • RESULTS: Patients taking topiramate had an average of 1 fewer drink per day, both on drinking days and on a daily basis, 15% fewer days of heavy drinking, and approximately 12% more days of abstinence compared with the placebo group. The numbers were even more significant at the end of the study, showing a trend in increasing efficacy over the 12 weeks of follow up. The anticraving effects were also more significant at the end than when averaged over the length of the study. Plasma GGT levels had a statistically significant drop during the study and obsessive-compulsive drinking scale factor scores decreased significantly. All 150 subjects completed the study, and they reported no adverse events.


 

PRACTICE RECOMMENDATIONS

Oral topiramate is effective in the treatment of alcohol dependence. Patients taking topiramate consumed less alcohol, had fewer heavy drinking days, and had more days abstinent within a 12-week period. This medication adds a significant adjunct to our current treatment of alcoholism and can be considered for use in treating those alcoholics who desire sobriety.

Recommended Reading

Does long-term bupropion (Zyban) use prevent smoking relapse after initial success at quitting smoking?
MDedge Family Medicine
How effective are pharmacologic agents for alcoholism?
MDedge Family Medicine
What is the most effective nicotine replacement therapy?
MDedge Family Medicine
Can 2 screening questions accurately detect alcohol and other drug abuse in the primary care setting?
MDedge Family Medicine
Direct Observation of Smoking Cessation Activities in Primary Care Practice
MDedge Family Medicine
Physicians’ Advice to Quit Smoking
MDedge Family Medicine
Use of Office-Based Smoking Cessation Activities in Family Practices
MDedge Family Medicine
Carbamazepine effective for alcohol withdrawal
MDedge Family Medicine
Does acetaminophen affect liver function in alcoholic patients?
MDedge Family Medicine
12-hour protocol safe for cocaine-associated chest pain
MDedge Family Medicine